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PredictiveAbstract Background: Patients with chronic pulmonary diseases are at increased risk of
hypoxemia when traveling by air. Screening guidelines, predictive equations based on ground level
measurements and altitude simulation laboratory procedures have been recommended for deter-
mining risk but have not been rigorously evaluated and compared. Therefore we aimed to explore
the correlation and concordance between hypoxic challenge testing and predictive equations for
assessment and prediction of in-ﬂight hypoxia in chronic obstructive pulmonary disease patients
prior to air travel.
Design: Comparative study.
Methods: Thirty ﬁve chronic obstructive pulmonary disease patients were studied. Spirometry
data were recorded prior to hypoxic inhalation test and blood gases were analyzed before and after
hypoxic inhalation and when SpO2 6 85%. Hypoxic inhalation test was performed using the ven-
timask method. The PaO2 at altitude was estimated using four published predictive equations,
which use values of PaO2 (ground) and lung function measurements to predict altitude PaO2.
Results were interpreted using the BTS recommendations for prescription of in-ﬂight oxygen and
to assess agreement between hypoxic inhalation test results and each of the predictive equations.
Results: Ground PaO2 was signiﬁcantly decreased following hypoxic inhalation test.
746 M. A. A. A. Khalifa, G.A.M. MohamedConclusions: The present study supports on-HCT as a reliable, on-invasive and continuous
methods determining the requirement for in-ﬂight O2 are relatively constant. Predictive equations
considerably overestimate the need for in-ﬂight O2 compared to hypoxic inhalation test. Predictive
equations are cheap, readily available methods of ﬂight assessment, but this study shows poor
agreement between their predictions and the measured individual hypoxic responses during HCT.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Hypoxic challenge testing (HCT) is also known as (hypoxia
altitude simulation test, high altitude simulation test or
hypoxic inhalation test).
Hypobaric hypoxia develops as a result of the inverse
relationship between oxygen partial pressure and altitude,
resulting in a decrease in the partial pressure of alveolar oxy-
gen (PaO2) during ascent, and leads to reduced oxygenation
of arterial blood. This occurs during travel in a pressurized
aircraft cabin as ambient pressure is decreased. Commercial
aircraft typically cruise at up to 40,000 feet (12,000 m). Engi-
neering and ﬁnancial constraints do not allow pressurization to
sea level, hence the aircraft cabin is pressurized to a maximum
altitude of 8000 feet (2438 m), which, with respect to oxygena-
tion, is equivalent to breathing 15% oxygen (O2) at sea level [1]
Increasing numbers of people with chronic respiratory diseases
wish to travel but may be unaware that the pressurized cabin
of a modern aircraft may be a physiologically challenging envi-
ronment to those with lung disease [2].
There is a wide variation in the individual response to the
hypobaric environment, the mechanisms of which are not
clearly understood [3]. Clinical manifestations of hypobaric
hypoxia include euphoria, headache, fatigue, lassitude,
dizziness and in extreme cases, if untreated can lead to
unconsciousness and even death [3].
Those patients who are hypoxic at sea level are thought to
be at greater risk of experiencing a decrease in PaO2 to a crit-
ical level and may develop severe hypoxia during ﬂight [4].
The British Thoracic Society (BTS) recommend that a pre-
ﬂight assessment be considered in all patients with respiratory
disease prior to air travel, to predict the likelihood of respira-
tory problems [5]. Hypobaric chambers are the ‘gold standard’
in ﬂight assessment, but they are expensive and not widely
available. Alternative methods used in clinical practice include
hypoxic challenge test (HCT) and predictive equations [6].
There is insufﬁcient information available to establish the
extent to which either method is used, but it seems reasonable
to assume that predictive equations are used more frequently
by clinicians (e.g. in primary health care) who do not have
access to the facilities required to perform an HCT.
The aim of this retrospective comparative study was to
explore the correlation and concordance between hypoxic
challenge testing and predictive equations for assessment and
prediction of in-ﬂight hypoxia in chronic obstructive pulmon-
ary disease patients prior to air travel.
Methods
This study is conducted as a nested study and a continuation
of study done by investigator was published previously on2011 [7], where written consent was obtained for all partici-
pants, and all participants were clinically stable at the time
of study.
Thirty-ﬁve volunteer participants had a clinical diagnosis
of COPD according to the GOLD criteria, a FEV1/FVC
ratio of less than 70% in a patient with a postbronchodila-
tor FEV1 of less than 80% of the predicted value [8].
Severity is further stratiﬁed based on symptoms and FEV1
values, where all participants fulﬁlled the following inclusion
criteria: Volunteer participants diagnosed COPD based on
usual clinical and functional grounds; a best recorded ratio
of forced expiratory volume in 1st to forced vital capacity
(FEV1/FVC) of less than 0.7, or a best recorded FEV1 that
ranged from 50% to 80% of the predicted value, in a stable
state of the disease, free of acute exacerbation which
excluded any one who has an evidence of ischemic heart dis-
eases, associated lung diseases such as (asthma, interstitial
lung diseases, bronchiectasis, pulmonary hypertension, lung
cancer), obesity {deﬁned by body mass index (BMI)P
30 kg/m2}, evidence of restrictive lung disease, or partici-
pants with other severe diseases that could inﬂuence survival
(hepatic cirrhosis, renal failure), uncontrolled diabetes melli-
tus. Finally participants who required O2 therapy were
excluded and of no concept for the study.
All participants were informed of any risks and discomfort
associated with the experiment, and written consent was
obtained.
As part of the characterization procedures, resting pulmon-
ary function testing, blood pressure, heart rate, respiratory rate
were recorded and inhaled hypoxic gases were carried out in all
participants.
According to the standardized operational procedures for
pulmonary function testing, a minimum of 3 and a maximum
of 5 tests were performed in each participant by (KoKo PFT
Spirometer PC-Based Ofﬁce Spirometry, Ferraris Respiratory,
Inc USA). The best spirometric maneuvers were recorded for
analyses.
Sufﬁcient rest time was assured between test of spirometry
and hypoxic challenge test (30 min) and until the ﬁrst test base-
line measurements were recorded, Arterial blood sample was
drawn from the participant while breathing ambient air, in
the morning from 9 to 12 Am, after a 15 min resting period
in the supine position for arterial blood gas.
Arterial blood was withdrawn from the radial artery with a
25-gauge needle attached to a heparinized syringe and immedi-
ately analyzed with a blood gas analyzer (ABL 700; Radiome-
ter; Copenhagen, Denmark).
All participants involved in the present study had per-
formed (plain X-ray chest PA and RT lateral views), fasting
and post prandial blood sugar, renal and liver laboratory tests
and ECG.
Hypoxic ﬂight assessment and prediction of hypoxia in COPD patients 747Pulse oximetric saturation (SPaO2) and pulse rate were
measured continuously using a portable pulse oximeter (3100
WristOx; Nonin Medical; Minneapolis, MN).
Pulse oximeter has been checked previously for accuracy.
All participants’ parameters were recorded.
Hypoxic challenge test
The HCT was performed using a technique described by Gong
et al. [9]. Calibration of equipment and measurement of lung
function indices were done in accordance with BTS guidelines
[10].
An HCT was performed using the Ventimask method [11].
This required delivery of 100% nitrogen through a 40% Ven-
timask at a designated ﬂow rate of 10 l/min. The Ventimask is
designed to entrain room air, which mixes with the nitrogen
within the mask, resulting in the equivalent inspired fraction
of oxygen (FiO2) of 15% O2. In order to verify the FiO2,
An oxygen analyzer probe was positioned in the side way
between the ventori and mask, thus permitting veriﬁcation of
the ﬁo2 (range 14.9–15.1).
Subjects inhaled a hypoxic gas mixture of 15% oxygen in a
nitrogen balance. Participants breathed through the HIT cir-
cuit via a mouthpiece, with a peg occluding the nose. SpO2
and pulse rate, non invasive blood pressure, and respiratory
rate were measured continuously for 20 min or until the
SpO2 was <85%, at that time an arterial blood sample was
taken, if SpO2 not down and still <85%. The second arterial
blood sample was taken after 20 min of starting the test.
The subject breathed the hypoxic gas mixture for a
maximum of 20 min or until SpO2 6 85% for more than one
minute and an arterial blood gas conﬁrmed PaO2 < 7.4 kPa
(<55.5 mmHg) [5].
All procedures were performed under close observation of
investigator, and not allowing the participant to return home
until his/her vital sign returns to pretest values.
The oxygen tension at altitude (PaO2 (Alt)) was calculated
using four published predictive equations based on values of
ground level PaO2 (breathing room air) and FEV1 to predict
PaO2 (Alt).
The predictive equations are given as examples in the cur-
rent BTS recommendations [1].
Equations 1–3 were developed by Dillard et al. [12]. Equa-
tion 1 incorporates PaO2 (ground) as a variable, equation 2
incorporates PaO2 (ground) and FEV1 (l) and Equation 3
incorporates PaO2 (ground) and FEV1% predicted. Equation
4 was developed by Gong et al. [9]. This equation incorporates
PaO2 (ground) as a variable.
Equations used for the calculation of PaO2 (Alt)Table 1 Criteria of excluded participants.
No of participants (10) Reasons of exclusion
Three participants (2#/1$) Ischemic heart diseases
Three participants (2#/1$) Obese BMI > 30 kg/m2
One # Uncontrolled diabetes mellitus
One # Hepatic impairment
One # Renal impairment
One # Participant known with pulmonary
hypertensioni. PaO2 (Alt) (mmHg) = 0.410 · PaO2 (ground) (mmHg)
+ 1.7652 [12].
ii. PaO2 (Alt) (mmHg) = 0.519 · PaO2 (ground) (mmHg)
+ 11.855 FEV1 (l)  1.760 [12].
iii. PaO2 (Alt) (mmHg) = 0.453 · PaO2 (ground) (mmHg)
+ 0.386 · (FEV1%) + 2.44 [12].
iv. PaO2 (Alt) (mmHg) = 22.8  (2.74 · altitude in
thousands of feet) + 0.68 · PaO2 (ground) (mmHg) [9].
A target altitude of 8000 feet (2438 m) was substituted into
Equation 4. The equations originate from studies that quote
feet and mmHg [9,12].
The results were interpreted according to the BTS
recommendations for the prescription of in-ﬂight O2 post
HCT: (I) PaO2 (Alt) > 7.4 kPa (>55.5 mmHg), in-ﬂight O2
not required; (II) PaO2 (Alt) < 6.6 kPa (<49.5 mmHg),
in-ﬂight O2 required; (III) PaO2 (Alt) 6.6–7.4 kPa (49.5–
55.5 mmHg), borderline for in-ﬂight O2, which may require
further investigation. These recommendations for the prescrip-
tion of in-ﬂight O2 are based on a consensus of expert medical
opinion [1,5].
Statistical analyses
The characteristics of the participants were summarized as
means (standard deviations [SDs]. The agreement between
PaO2 post HCT and PaO2 (Alt) estimated from the equations
were studied by correlation coefﬁcients, mean and SD of the
PaO2 post HCT – PaO2 (Alt) estimated from the equations,
and the Bland–Altman plot. Paired t tests were used to study
the signiﬁcance of any difference. The agreement between
PaO2 post HCT and PaO2 (Alt) estimated from the equations
were further studied by exploring associations with speciﬁc
patient characteristics. The group means, SDs and correlations
of the difference between and the average of PaO2 post HCT
and PaO2 (Alt) estimated from the equations measurements
were studied. The independence between the difference and
the average was shown by the Bland–Altman method. The
signiﬁcance level was set as 5%. Statistical analyses were
performed with MedCalc software. (Version 13.1.2 – Last
modiﬁed: April 10, 2014).
Results
Summary of patients characteristics
Forty ﬁve recruited volunteer participants with documented
COPD were involved in this study. Ten participants (2 female
and 8 male) were excluded from this study because they did not
follow the inclusion criteria (Table 1).
The remaining thirty ﬁve participitants (33 males and 2
females) completed the challenge and their baseline data are
shown in (Table 2) where their mean age 49.86 ± 4.85 (SD)
ranged from 40 to 60 years.
Pulmonary function testing results were reported using
absolute values (Table 2), where the mean forced expiratory
volume in 1st second (FEV1) was 2.49 ± .698 (L) and mean
forced expiratory volume in 1st second/forced vital capacity,
was 59.55 ± 4.76.
The mean value of SpO2 at rest was (96.06 ± 1.03), and it
decreased to (89 ± 3.69) at the end test, with mean difference
Table 2 Age, Respiratory Function Parameters and PaO2 for
participants.
Participants (n= 35) Range Mean ± SD
Min Max
Age 40.00 60.00 49.86 ± 4.85
FEV1 L .98 3.78 2.49 ± .698
FEV1% 57.00 89.00 75.57 ± 11.73
FVC L .85 1.83 1.29 ± .22
FVC% 17.03 52.50 31.53 ± 9.3
FEV1 /FVC% 48.00 67.00 59.55 ± 4.76
SPaO2 at rest 94.00 98.00 96.06 ± 1.03
PaO2 at rest 69.10 89.00 77.75 ± 5.43
PaO2 post hypoxic challenge test 61 75 66.06 ± 3.718
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(P< 0.01) reduction in SpO2.
The mean value of PaO2 at rest was (77.75 ± 5.43), and it
decreased to (66.06 ± 3.718) at the end of test, with mean dif-
ference value of 11.6, and this revealed statistical signiﬁcance
(P< 0.01) reduction in PaO2.
Results of hypoxic challenge test were interpreted according
to the BTS recommendations for the prescription of in-ﬂight
O2.
The mean difference between PaO2 measured (before and
after HCT) and estimated by equations is shown in Fig. 1.
In this study, in-ﬂight oxygen is deﬁnitely not required,
based on the hypoxic challenge test results and according to
British Thoracic Society guidelines, where PaO2 post test was
more than 60 mmHg. On the other hand, supplemental in-
ﬂight oxygen will be recommended for all participants where
PaO2 is less than 50 mmHg according to prediction of PaO2
estimated by Equation I, while supplemental in-ﬂight oxygen
will be recommended to 4 and 9 participants according to pre-
diction of PaO2 estimated by Equations II and IV respectively,
in add to supplemental in-ﬂight oxygen not to be recom-
mended for all participants according to value of PaO2
estimated by Equation III were it is more than 60 mmHg
Table 3, Fig. 2.Figure 1 PaO2 value before and afterThe correlation between PaO2 post HCT and PaO2
estimated by Equation 1 was 0.479 (P= 0.0036), which is
moderate and signiﬁcant, Table 4.
The mean of the difference between the readings (PaO2
post HCT minus PaO2 estimated by Equation 1) was
32.3705 mmHg (SD, 3.28542; 95% conﬁdence interval (CI),
31.2419 to 33.49909 mmHg). The mean difference was signiﬁ-
cant (P< 0.0001) based on a paired t test. The Bland–Altman
analysis is shown in Figs. 3a–c.
The limits of agreement (mean ± 2SDs) were 25.8015–
38.944 mmHg. The range was too large to be acceptable. It
was evident that the differences did not scatter around zero,
and there was a linear trend. The correlation between the dif-
ference and the average of PaO2 post HCT and PaO2 estimated
by Equation 1 values 0.479 (P= 0.0036)The linear trend
showed that on average, the difference between the PaO2 post
HCT and PaO2 estimated by Equation 1 readings increased.
Therefore, the bias was not constant but depended on the
value of the reading, and thus the PaO2 value could not be
obtained by simply adding a consistent bias to the PaO2 value
estimated by Equation 1.
The correlation between PaO2 post HCT and PaO2 esti-
mated by Equation 2 was 0.3616 (P= 0.0328), which is mod-
erate and signiﬁcant (Table 4).
The mean of the difference between the readings (PaO2
post HCT minus PaO2 estimated by Equation 2) was
12.16037 mmHg (SD, 4.54020; 95% conﬁdence interval [CI],
10.60076–13.71998 mmHg). The mean difference was signiﬁ-
cant (P< 0.0001) based on a paired t test. The Bland–Altman
analysis is shown in Figs. 4a–c.
The limits of agreement (mean ± 2 SDs) were 3.08–
21.2408 mmHg. The range was too large to be acceptable. It
was evident that the differences did not scatter around zero,
and there was a linear trend. The correlation between the dif-
ference and the average of PaO2 post HCT and PaO2 estimated
by Equation 2 values 0.3616 (P= 0.0328).The linear trend
showed that on average, the difference between the PaO2 post
HCT and PaO2 estimated by Equation 2 readings increased.
Therefore, the bias was not constant but depended on the
value of the reading, and thus the PaO2 value could not beHCT and estimated by equations.
Table 3 Comparison of hypoxic challenge test versus predictive equations.
PoaO2 (Alt) (mmHg) Participant (n = 35) Mean ± SD In-ﬂight O2 recommended according to BTS recommendations
No Border line Yes
Post HCT PaO2 66.06 ± 3.718 35 0 0
Equation I 33.6866 ± 2.16756 0 0 35
Equation II 53.8968 ± 4.27692 4 11 20
Equation III 66.8799 ± 5.29525 35 0 0
Equation IV 53.8229 ± 3.59498 9 21 5
Figure 2 Sequence Plot of PaO2 values at rest before and after hypoxic challenge test versus predictive equations.
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Figure 3a Scatter plot of PaO2 post HCT against PaO2 estimated by Equation 1.
Table 4 Correlations of partial pressures of oxygen in participants with chronic obstructive airway disease measured in room air (pre-
challenge), with hypoxic challenge test and estimated by equations.
Participants (35) PaO2 Predicted PaO2 (Alt)
Initial before test Post H I T Equation 1 Equation 2 Equation 3 Equation 4
PaO2 Initial before test Pearson Correlation 1 .479
** 1.000** .799** .524** 1.000**
Sig. (2-tailed) .004 .000 .000 .001 .000
Post H C T Pearson Correlation .479** 1 .479** .362* .273 .479**
Sig. (2-tailed) .004 .004 .033 .112 .004
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
* Correlation is signiﬁcant at the 0.05 level (2-tailed).
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Figure 3b Correlation of PaO2 post hypoxic inhalation test
against PaO2 estimated by equation I.
750 M. A. A. A. Khalifa, G.A.M. Mohamedobtained by simply adding a consistent bias to the PaO2 value
estimated by Equation 2.
The correlation between PaO2 post HCT and PaO2 esti-
mated by Equation 3 was 0.2732 (P= 0.1123), which is mild
and signiﬁcant (Table 4).
The mean of the difference between the readings (PaO2 post
HCT minus PaO2 estimated by Equation 3) was 8226 mmHg
(SD, 5.57703; 95% conﬁdence interval [CI], 2.73849 to
1.09306 mmHg). The mean difference was signiﬁcant
(P< 0.3890) based on a paired t test. The Bland–Altman anal-
ysis is shown in Figs. 5a–c.
The limits of agreement (mean ± 2 SDs) were 10.3314–
11.9766 mmHg. The range was too large to be acceptable. It
was evident that the differences did not scatter around zero,
and there was a linear trend. The correlation between the dif-
ference and the average of PaO2 post HCT and PaO2 estimated
by Equation 3 values 0.4793 (P= 0.0036)The linear trend30 32 34
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Figure 3c Bland–Altman plot of PaO2 post hypoxic inshowed that on average, the difference between the PaO2 post
HCT and PaO2 estimated by Equation 3 readings increased.
Therefore, the bias was not constant but depended on the
value of the reading, and thus the PaO2 value could not be
obtained by simply adding a consistent bias to the PaO2 value
estimated by Equation 3.
The correlation between PaO2 post HCT and PaO2
estimated by Equation 4 was 0.4793 (P= 0.0036), which is
moderate and signiﬁcant.
The mean of the difference between the readings (PaO2
post HCT minus PaO2 estimated by Equation 4) was
12.2343 mmHg (SD, 3.7326; 95% conﬁdence interval [CI],
10.95208 to 13.51649 mmHg). The mean difference was signif-
icant (P< 0.0001) based on a paired t test. The Bland–Altman
analysis is shown in Figs. 6a–c.
The limits of agreement (mean ± 2 SDs) were 4.8591–
19.7895. The range was too large to be acceptable. It was
evident that the differences did not scatter around zero, and
there was a linear trend. The correlation between the difference
and the average of PaO2 post HCT and PaO2 estimated by
Equation 4 values 0.479 (P= 0.0036). The linear trend showed
that on average, the difference between the PaO2 post HCT
and PaO2 estimated by Equation 4 readings increased. There-
fore, the bias was not constant but depended on the value of
the reading, and thus the PaO2 value could not be obtained
by simply adding a consistent bias to the PaO2 value estimated
by Equation 4.
Discussion
Patients with COPD are potentially at risk from altitude-
induced hypoxemia and from expansion of gases within closed
body cavities (bullae and pneumothoraces). However, the fre-
quency of severe air travel-related adverse events is low in
these patients, who generally tolerate moderate hypoxemia36 38 40
uation 1 and post HCT
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Figure 4a Scatter plot of PaO2 post HCT against PaO2 estimated by Equation 2.
Figure 4b Correlation of PaO2 post hypoxic inhalation test
against PaO2 estimated by Equation 2.
Hypoxic ﬂight assessment and prediction of hypoxia in COPD patients 751well. Patients with severe COPD (FEV1 < 30% predicted)
should consult their specialist beforehand and should carry
their usual medication, spacer, and emergency prednisolone
in their hand luggage. Pulse oximetry can be performed in pri-
mary care to identify signiﬁcant hypoxemia and such patients
should be referred for HCT [13].
The purpose of HCT is to determine the need for in-ﬂight
oxygen by exposing the patient to the hypoxia experienced at
a cabin altitude of 8000 feet and measuring hypoxemia. It is
not a ‘ﬁtness to ﬂy’ test. The test is performed in a specialist
lung function unit. The maximum cabin altitude of 8000 feet
can be simulated using a mixture containing 15% oxygen in
nitrogen, which the patient is required to breathe for 20 min
[9,14].
A full simulation can only be performed in a hypobaric
chamber, but this is rarely required. HCT should be considered
in patients in a risk group, who are not already receiving
LTOT at sea level and whose oxygen saturation (SpO2) at rest
is <95% breathing air. Pulse oximetry should permit GPs toassess resting oxygen saturation and determine the need for
referral. Patients already receiving LTOT at sea level should
be prescribed in-ﬂight oxygen at double their usual ﬂow rate
while at cruising altitude; they do not require HCT. Although
HCT is considered to be the clinical ‘gold standard’ for pre-
dicting in-ﬂight hypoxemia, it is time-consuming and is not
universally available [13].
The current BTS recommendation provides four equations
for predicting PaO2(Alt), all developed exclusively from studies
investigating the hypoxic response of COPD participants
[5,9,12]. Several prediction equations have been derived to esti-
mate in-ﬂight arterial oxygen tension (PaO2) or SpO2 from sea
level measurements and are detailed in the latest BTS recom-
mendations [15].
When assessing a patient with chronic respiratory disease
planning air travel, careful consideration must be given to their
overall clinical status. The response to hypobaric hypoxia is
variable and inﬂuenced by a number of factors, including car-
diac and respiratory status, anemia, sea-level arterial blood
gases, blood carboxyhemoglobin and age [3]. Passengers are
also more likely to sleep during long-haul ﬂights, resulting in
hypoventilation which may further decrease PaO2 (Alt) [16].
An HCT simulates one aspect of altitude exposure, i.e. the
inhalation of a low inspired fraction of oxygen (FiO2) such as
is encountered at altitude, typically 8000 feet (2438 m). This is
normally the maximum operational cabin altitude; however,
this altitude can be exceeded to avoid adverse weather condi-
tions and is also dependent on individual aircraft design char-
acteristics [3]. An HCT also allows correction of induced
hypoxia by titration of supplemental O2, thus enabling correct
prescription of in-ﬂight O2.
Naughton et al. [17] compared the hypoxic response of six
normal control subjects and nine patients with chronic airﬂow
obstruction using HCT and a hypobaric chamber at 6000 feet
(1829 m) and 8000 feet (2438 m). They found no signiﬁcant dif-
ference between arterial blood gas measurements obtained
using either method.
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Figure 4c Bland-Altman Plot of PaO2 post hypoxic inhalation test against PaO2 estimated by Equation 2.
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Figure 5a Scatter plot of PaO2 post HCT against PaO2 estimated by Equation 3.
752 M. A. A. A. Khalifa, G.A.M. MohamedKelly et al. [18] compared SpO2 measured during HCT and
during an actual ﬂight in 15 normal subjects. They found no
signiﬁcant difference between the ﬁnal HCT SpO2 and the
mean in-ﬂight SpO2. These results agree the idea of this study
for use of HCT in prediction of hypoxia and ﬂight assessment
in chronic obstructive pulmonary disease patients prior to air
travel.
Dillard et al. [12] studied the hypoxic response of eighteen
subjects with severe COPD, FEV1 31(10)%. The results
showed that PaO2 (ground) had the highest correlation with
PaO2 (Alt) (r= 0.587; p< 0.01), Equation 1. They also found
that the variability in PaO2 (Alt) could only be partially
explained by PaO2 (ground), and that using lung function mea-
surements as the additional predictor variables signiﬁcantly
increased the correlation between PaO2 (ground) and PaO2(Alt) (r= 0.847; p< 0.0001) (Equations 2 and 3). Gong
et al. [9]. Also studied the hypoxic response of 22 subjects with
COPD with a range of airﬂow obstruction FEV1 44(17)%,
they also found PaO2 (ground) to be the best predicator of
PaO2 (Alt) (r= 0.87; p< 0.0005) Equation 4. Unlike Dillard
[12], Gong [9] found that inclusion of lung function measure-
ments did not improve the predictability of the PaO2 (Alt).
Our study examined the hypoxic response of 35 participants
with mild to moderate COPD, and the results show that the
application of Equations 1, 2, 3 and 4 provided signiﬁcant
variability in PaO2 (Alt) and all participants were in needed
of in-ﬂight O2 by application of Equation 1, while by using
Equation III none of the studied participants needed in-ﬂight
O2. On other hand participants 4 and 9 were in need of in-ﬂight
O2 when using equations II and IV respectively. But Dillard
Figure 5b Correlation of PaO2 post hypoxic inhalation test
against PaO2 estimated by Equation 3.
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Figure 5c Bland-Altman Plot of PaO2 post hypoxic inhalation test against PaO2 estimated by Equation 3.
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Figure 6a The scatter plot of PaO2 post HCT against PaO2 estimated by Equation 4. The variation of the scatters around the regression
line was moderate.
Figure 6b Correlation of PaO2 post hypoxic inhalation test
against PaO2 estimated by Equation 4.
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Figure 6c Bland-Altman Plot of PaO2 post hypoxic inhalation test against PaO2 estimated by Equation 4.
754 M. A. A. A. Khalifa, G.A.M. Mohamedet al. [11] studied the hypoxic response of eighteen subjects
with severe COPD, FEV1 31(10)%. The results showed that
PaO2 (ground) had the highest correlation with PaO2 (Alt)
(r= 0.587; p< 0.01), Equation 1. They also found that the
variability in PaO2 (Alt) could only be partially explained by
PaO2 (ground), and that using lung function measurements
as the additional predictor variables signiﬁcantly increased
the correlation between PaO2 (ground) and PaO2 (Alt)
(r= 0.847; p< 0.0001) (Equations 2 and 3). Gong et al. [9]
also studied the hypoxic response of 22 subjects with COPD
with a range of airﬂow obstruction FEV1 44(17)%. They also
found PaO2 (ground) to be the best predicator of PaO2 (Alt) (r
0.87; p< 0.0005) Equation 4. Unlike Dillard [12], Gong [9]
found that inclusion of lung function measurements did not
improve the predictability of the PaO2 (Alt).
The previous studies would support our study in that the
study of Martin et al. [19] examined the hypoxic response of
15 subjects with moderate COPD, FEV1 38(13)% and the
results show that the application of Equations 1, 2, 3 and 4
in the COPD group signiﬁcantly overestimates PaO2 (Alt)
and thus the need for in-ﬂight O2. This ﬁnding is supported
by a previous study done by Kelly et al. [18], which also found
Equation 4 overestimated PaO2 (Alt) in subjects with moder-
ate/severe COPD.
Given the complex physiological variables that inﬂuence an
individual’s hypoxic response, it is not surprising that there is
poor agreement between the measured individual responses
and the results obtained from the predictive equations. The
current BTS recommendations state that some centers still
use predictive equations as a method of ﬂight assessment [5].
All predictive equations used to assess ﬁtness to ﬂy include
PaO2 (ground) as a predictor variable, but there is conﬂicting
evidence with regard to its usefulness in predicting PaO2 (Alt)
[1,9,12,20–22].
Predictive equations also do not allow the signs and symp-
toms of hypoxia to be evaluated. For this reason the American
Thoracic Society now recommends that predictive equations
be used as a screening tool to identify patients with borderline
PaO2 (Alt) estimates, for further investigation with HCT [22].Two studies have shown subjects with PaO2 (ground) >
9.3 kPa (>69.76 mmHg), (SpO2 > 95%) values in whom
further assessment was not recommended, but who developed
signiﬁcant hypoxia during ﬂight [20,23]. Other studies had
found that although at altitude PaO2 (Alt) dropped below
the recommended critical value, none of the subjects developed
any hypoxic symptoms [24].
In centers that use predictive equations as a method of
ﬂight assessment, it should be highlighted that determining
the requirement for in-ﬂight O2 and the speciﬁc ﬂow rate at
which it should be administered has important implications
for the patient. General practitioners can prescribe portable
O2, and some airlines permit its use [25], but an accurate ﬂow
rate is needed to ensure that cylinder capacity is adequate for
the ﬂight duration. This degree of speciﬁcity can only be
achieved by individual assessment of the hypoxic response,
and cannot be achieved using predictive equations [19].
Predictive equations may be a cheaper and simpler alterna-
tive to an HCT, particularly in the primary-care setting, but
they considerably overestimate the need for in-ﬂight O2 in
the majority of patients [19].
The results of the current study would support the use of
predictive equations as screening tools only. Patients for whom
the equations indicate ﬁtness to ﬂy should be allowed to ﬂy
without further testing, but patients for whom the predictive
equations indicate critical or borderline in-ﬂight PaO2 (Alt)
values should be re-evaluated in a center with HCT facilities
or with access to a hypobaric chamber before discouraging
such patients from ﬂying or alternatively prescribing in-ﬂight
oxygen based on the predictive equation calculation alone.
Conclusions
The present study supports on-HCT as a reliable, non-invasive
and continuous method determining the requirement for
in-ﬂight O2 is relatively constant. Predictive equations consid-
erably overestimate the need for in-ﬂight O2 compared to
hypoxic inhalation test. Predictive equations are a cheap, read-
ily available method of ﬂight assessment, but this study shows
Hypoxic ﬂight assessment and prediction of hypoxia in COPD patients 755poor agreement between their predictions and the measured
individual hypoxic responses during HCT.
Conﬂict of interest
None declared.
‘‘The authors deny any conﬂicts of interest’’, or involve-
ment with any commercial organization with direct ﬁnancial
interest in the subject or materials discussed in this manuscript.
The signatures of all the authors are appended in the cover
letter for the same.
Footnotes source of support
Nil.
Authors’ contribution
Mohie Aldeen Abd Alzaher Khalifa (Study design, method,
Data collection and draft writing), Gamal Aldeen M Moham-
ed (Statistical analysis and draft writing).
Acknowledgements
I wish to thank the volunteer patients without whom this study
would not have been possible.
References
[1] L.M. Seccombe, M.J. Peters, Oxygen supplementation for
chronic obstructive pulmonary disease patients during air
travel, Curr. Opin. Pulm. Med. 12 (2006) 140–144.
[2] Airports Council International. Paxﬂash summary Oct 2006.
<http://www.aci.aero/cda/aci/display/main/
aci_content.jsp?zn=aci&cp=1-5-212-218-22_.html>, (accessed
Dec 2006).
[3] Ernsting J, Nicholson AN, Rainford DJ, eds. Aviation Medicine
(2000) 3. Oxford: Butterworth-Heinemann.
[4] A.O.C. Johnson, Safe air travel with respiratory disease, Asthma
J. 34 (1997) 52–54.
[5] British Thoracic Society Standards of Care Committee. In:
Managing passengers with respiratory disease planning air
travel: Summary for primary care. <http://www.brit-
thoracic.org.uk/c2/uploads/FlightPCsummary04.pdf>,
(accessed Oct 2005).
[6] R.K. Coker, M.R. Partridge, Assessing the risk of hypoxia in
ﬂight: the need for more rational guidelines, Eur. Respir. J. 15
(2000) 128–130.
[7] Mohie Aldeen Abd Alzaher Khalifa, Hypoxia Altitude
Simulation Test for Evaluation of Patients with Chronic
Obstructive Airway Disease Prior To Air Travel, Egypt. J.
Chest Dis. Tuberculosis 60 (1) (2011) 79–86.
[8] Global Initiative for Chronic Obstructive Lung Disease
(GOLD), Global strategy for diagnosis, management, and
prevention of chronic obstructive pulmonary disease updated
2010. (Online) (Cited 2011 March). Available from URL: http://
www.goldcopd.com.[9] H. Gong Jr., D.P. Tashkin, E.Y. Lee, M.S. Simmons, Hypoxia-
altitude simulation test. Evaluation of patients with chronic
airway obstruction, Am. Rev. Respir. Dis. 130 (1984) 980–986.
[10] Guidelines for the measurement of respiratory function,
Recommendations of the British Thoracic Society and the
Association of Respiratory Technicians and Physiologists,
Respir. Med. 38 (1994) 165–194.
[11] K.P. Vohra, R.A. Klocke, Detection and correction of
hypoxemia associated with air travel, Am. Rev. Respir. Dis.
148 (1993) 1215–1219.
[12] T.A. Dillard, B.W. Berg, K.R. Rajagopal, J.W. Dooley, W.J.
Mehm, Hypoxemia during air travel in patients with chronic
obstructive pulmonary disease, Ann. Intern. Med. 111 (1) (1989)
362–367.
[13] L.K. Josephs, R.K. Coker, M. Thomas, on behalf of the BTS
Air Travel Working Group. Managing patients with stable
respiratory disease planning air travel: a primary care summary
of the British Thoracic Society recommendations. Prim. Care
Respir. J. 22(2) (2013) 234–238.
[14] T.A. Dillard, L.K. Moores, K.L. Bilello, Y.Y. Phillips, The
preﬂight evaluation: a comparison of the hypoxia inhalation test
with hypobaric exposure, Chest 107 (2) (1995) 352–357.
[15] S. Ahmedzai, I.M. Balfour-Lynn, T. Bewick, et al, Managing
passengers with stable respiratory disease planning air travel:
British Thoracic Society recommendations, Thorax 66 (Suppl. 1)
(2011) i1–i30.
[16] W.T. McNicholas, Impact of sleep on ventilation and gas
exchange in chronic lung disease, Monaldi Arch. Chest Dis. 59
(2003) 212–215.
[17] M.T. Naughton, P.D. Rochford, J.J. Pretto, R.J. Pierce, N.F.
Cain, L.B. Irving, Is normobaric simulation of hypobaric
hypoxia accurate in chronic airﬂow limitation?, Am J. Respir.
Crit. Care Med. 152 (1995) 1956–1960.
[18] T. Kelly, M.P. Swanney, C. Frampton, L.M. Seccombe, et al,
Normobaric hypoxia inhalation test vs. response to airline ﬂight
in healthy passengers, Aviat. Space Environ. Med. 77 (2006)
1143–1147.
[19] S.E. Martin, J.M. Bradley, J.B. Buick, I. Bradbury, J.S. Elburn,
Flight assessment in patients with respiratory disease: hypoxic
challenge testing vs. predictive equations, Q. J. Med. 100 (2007)
361–367.
[20] A. Akero, C.C. Christensen, A. Edvardsen, O.H. Skjonsberg,
Hypoxaemia in chronic obstructive pulmonary disease patients
during a commercial Flight, Eur. Respir. J. 25 (2005) 725–730.
[21] D. Peckham, A. Watson, K. Pollard, C. Etherington, S.P.
Conway, Predictors of desaturation during formal hypoxic
challenge in adult patients with cystic ﬁbrosis, J. Cyst. Fibros.
1 (2002) 281–286.
[22] American Thoracic Society. Air travel. <http://
www.thoracic.org/COPD/12/points.asp>, (accessed Dec 2006).
[23] C.C. Christensen, M. Ryg, O.K. Refvem, O.H. Skjonsberg,
Development of severe hypoxaemia in chronic obstructive
pulmonary disease patients at 2438 m (8000 ft) altitude, Eur.
Respir. J. 15 (2000) 635–639.
[24] R. Fischer, S.M. Lang, K. Bruchner, H.X. Hoyer, et al, Lung
function in adults with cystic ﬁbrosis at altitude: impact on air
travel, Eur. Respir. J. 25 (2005) 718–724.
[25] The Department of Health. Home oxygen service. <http://
www.dh.gov.uk/policyandguidance/
medicinespharmacyandindustry/prescriptions/
homeoxygenservice/index.htm>, (accessed Jan 2007).
